BREXOGEN Inc.
PrivateLast Round
Series C
Sep 1, 2023
Total Funding Raised
$25.82M
Company Overview
BREXOGEN Inc. is a biotechnology company that develops cell-free regenerative medicines using its proprietary stem cell-derived exosome platform technology to target incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BREXOGEN Inc. Comparables
Compare BREXOGEN Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExoStemTech | 87% | |
| ILIAS Biologics Inc. | 87% | |
| EXORPHIA Inc. | 84% | |
BREXOGEN Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2023 | ||||
| Series B | Dec 1, 2021 | ||||
| Series A | Sep 21, 2020 | ||||
| Pre Seed | Oct 1, 2019 |
BREXOGEN Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series B, Series C, Series A |
| Korea Investment Partners | Series B, Series C, Series A |
| Timefolio Asset Management | Series B, Series C, Pre Seed, Series A |
| Stonebridge Ventures | Series A |
| KB Securities | Series B, Series A |
| Korea Development Bank | Series B, Series C |
| Korea Venture Investment Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2023
$9M round with participation from Timefolio Asset Management and UTC Investment.
- Oct 1, 2019
$2.1M round from Tigris Investment and Timefolio Asset Management.
BREXOGEN Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BREXOGEN Inc.'s valuation, stock price, and market status.